Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ernst, P.
Right arrow Articles by Killmann, S.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ernst, P.
Right arrow Articles by Killmann, S.-A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1973, Vol. 41, No. 4, pp. 497-504.
© 1973 American Society of Hematology, Inc.


Biochemical Abnormality of DNA Synthesis of Erythroblasts in Acute and Chronic Myeloid Leukemia

Peter Ernst 1, Michele Baccarani 1, and Sven-Aage Killmann 1

1 Division of Hematology, Department of Medicine A, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.

Six patients with acute and chronic myeloid leukemia (AML and CML) showed a low incorporation of labeled DNA precursors into basophilic erythroblasts. Based on mitotic indices and the use of vincristine as a stathmokinetic tool, it was evident that brisk proliferation in this cell compartment took place. Microspectrophotometric determination of single-cell DNA content showed that a considerable fraction of the erythroid cells were in DNA synthesis without incorporating an exogeneously supplied DNA precursor. Following inhibition of the de novo synthesis of nucleoside triphosphates, the cells showed capacity for precursor incorporation. It is suggested that a biochemical abnormality, which leads to a high intranuclear nucleoside triphosphate pool, may inhibit nucleoside kinases and hence the utilization of labeled nucleosides, as well as diluting the labeled precursors. The defect should probably be considered to be a biochemical expression of "leukemicness" of the erythroid cells. The frequency of the phenomenon described here cannot be determined from the present study. The patients are part of a series of 44 patients who were studied with the purpose to investigate the effect of cytostatic treatment on the cell cycle of the leukemic cells. Many of the patients had so little erythropoiesis left that studies as those described here could not be carried out. Therefore, the reported frequency of 6/44 of the observed phenomenon is almost certainly an underestimate. Consequently, cytokinetic studies of erythropoiesis in CML and AML, using tracer techniques alone, must be evaluated with caution.

Submitted on July 10, 1972
Revised on August 21, 1972
Accepted on August 23, 1972


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1973 by American Society of Hematology         Online ISSN: 1528-0020